In summary, our mechanistic studies (summarized in Figure 6) provide evidence that CDK7 activates ER-α phosphorylation at Ser118 which enhances the transcription of MYC in ER+ breast cancer (Figure 6, pathway 1). The gene discussed is CDK7; the disease is breast carcinoma.